Jonathan regularly represents issuers and investment banks in connection with billions in securities offerings, including IPOs, secondary offerings, registered direct offerings, PIPEs, Rule 144A offerings and foreign offerings. He regularly advises public companies, including SPS Commerce, Tactile Medical, PARTS iD, Miromatrix Medical, iMedia Brands, Brickell Biotech and FCCC on SEC reporting, corporate governance, resales of restricted securities and equity compensation challenges. He also represents public companies in connection with other capital market transactions, including going private transactions, issuer tender offers for debt and equity, accelerated stock repurchases, and other security purchase programs.
Mergers and Acquisitions
Jonathan represents buyers and sellers in a variety of public and private transactions. He also represents investment banks in their role as financial advisor in M&A transactions, including with deal structuring, fairness opinions and engagement letters. Recently, he represented Endocyte, CoLucid Pharmaceuticals and Datalink in their public company sale transactions.
Jonathan represents emerging companies, venture capital funds, hedge funds and private equity funds in private placements of debt and equity securities. He also represents public companies in their strategic investments. In the past few years, he has advised the issuers in three of the largest venture capital transactions in Minnesota history.
In addition to traveling the world to places off the beaten path, Jonathan regularly competes in triathlons and once ran his own record label.